109 related articles for article (PubMed ID: 1608904)
1. Esterase activity toward the diastereomers of cefuroxime axetil in the rat and dog.
Mosher GL; McBee J; Shaw DB
Pharm Res; 1992 May; 9(5):687-9. PubMed ID: 1608904
[No Abstract] [Full Text] [Related]
2. Stereoselective absorption and hydrolysis of cefuroxime axetil diastereomers using the Caco-2 cell monolayer model.
Barrett MA; Lawrence MJ; Hutt AJ; Lansley AB
Eur J Drug Metab Pharmacokinet; 1997; 22(4):409-13. PubMed ID: 9512942
[TBL] [Abstract][Full Text] [Related]
3. Intestinal transport of cefuroxime axetil in rats: absorption and hydrolysis processes.
Ruiz-Balaguer N; Nacher A; Casabo VG; Merino Sanjuan M
Int J Pharm; 2002 Mar; 234(1-2):101-11. PubMed ID: 11839441
[TBL] [Abstract][Full Text] [Related]
4. Nonlinear intestinal absorption kinetics of cefuroxime axetil in rats.
Ruiz-Balaguer N; Nacher A; Casabo VG; Merino M
Antimicrob Agents Chemother; 1997 Feb; 41(2):445-8. PubMed ID: 9021205
[TBL] [Abstract][Full Text] [Related]
5. Photoisomerization kinetics of cefuroxime axetil and related compounds.
Fabre H; Ibork H; Lerner DA
J Pharm Sci; 1994 Apr; 83(4):553-8. PubMed ID: 8046613
[TBL] [Abstract][Full Text] [Related]
6. The relationship of diastereomer hydrolysis kinetics to shelf-life predictions for cefuroxime axetil.
Nguyen NA
Pharm Res; 1991 Jul; 8(7):893-8. PubMed ID: 1924141
[TBL] [Abstract][Full Text] [Related]
7. Cefuroxime axetil in the sick elderly patient.
Cowling P; Case CP; MacGowan AP; Lovering AM; Humphreys H; Reeves DS; Madan I; Harding M; Harvey JE
J Antimicrob Chemother; 1992 Mar; 29(3):350-1. PubMed ID: 1592706
[No Abstract] [Full Text] [Related]
8. Measurement of rat-intestinal cefuroxime axetil esterase activity: comparison of an h.p.l.c. and coupled-enzyme assay.
Campbell CJ; Langley C
Xenobiotica; 1985 Dec; 15(12):1011-9. PubMed ID: 2936009
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and absolute bioavailability of oral cefuroxime axetil in the rat.
Ruiz-Carretero P; Nacher A; Merino-Sanjuan M; Casabo VG
Int J Pharm; 2000 Jul; 202(1-2):89-96. PubMed ID: 10915930
[TBL] [Abstract][Full Text] [Related]
10. Comparative bioavailability of cefuroxime axetil suspension formulations administered with food in healthy subjects.
Mendes GD; Borges A; de Cássia Val L; Patni AK; Reyar S; Monif T; Sereno D; Orellana AM; De Nucci G
Arzneimittelforschung; 2010; 60(2):101-5. PubMed ID: 20329659
[TBL] [Abstract][Full Text] [Related]
11. Penetration of oral cefuroxime axetil into the human aqueous humor.
Ghia M; Lotti R; Traverso C; Mattioli F; Martelli A
Ophthalmologica; 1997; 211(4):229-31. PubMed ID: 9216013
[TBL] [Abstract][Full Text] [Related]
12. Purification and partial characterization of rat intestinal cefuroxime axetil esterase.
Campbell CJ; Chantrell LJ; Eastmond R
Biochem Pharmacol; 1987 Jul; 36(14):2317-24. PubMed ID: 3606643
[TBL] [Abstract][Full Text] [Related]
13. Effect of food on pharmacokinetics of cefuroxime axetil in Chinese subjects.
Chen RR; Lee TY; Hsieh WC
J Formos Med Assoc; 1992 Dec; 91(12):1177-81. PubMed ID: 1363640
[TBL] [Abstract][Full Text] [Related]
14. [Stepwise therapy of community-acquired pneumonia. Results of cefuroxime and cefuroxime axetil study].
Iakovlev SV; Suvorova MP; Dvoretskiĭ LI; Vlasenko NA; Shakhova TV
Antibiot Khimioter; 1998; 43(6):7-11. PubMed ID: 9644527
[TBL] [Abstract][Full Text] [Related]
15. Species dependent esterase activities for hydrolysis of an anti-HIV prodrug glycovir and bioavailability of active SC-48334.
Cook CS; Karabatsos PJ; Schoenhard GL; Karim A
Pharm Res; 1995 Aug; 12(8):1158-64. PubMed ID: 7494828
[TBL] [Abstract][Full Text] [Related]
16. Species differences in the disposition of propranolol prodrugs derived from hydrolase activity in intestinal mucosa.
Yoshigae Y; Imai T; Aso T; Otagiri M
Life Sci; 1998; 62(14):1231-41. PubMed ID: 9570338
[TBL] [Abstract][Full Text] [Related]
17. An evaluation of the penetration of cefuroxime axetil into human paranasal sinus tissue.
Sudderick RM; Lund VJ; Thomson JP; McCombe A; Mackay IS
Rhinology; 1992 Mar; 30(1):11-6. PubMed ID: 1579807
[TBL] [Abstract][Full Text] [Related]
18. Cefuroxime concentrations in serum, joint fluid and bone in elderly patients undergoing arthroplasty after administration of cefuroxime axetil.
Renneberg J; Christensen OM; Thomsen NO; Tørholm C
J Antimicrob Chemother; 1993 Nov; 32(5):751-5. PubMed ID: 8125839
[No Abstract] [Full Text] [Related]
19. Bioavailability of cefuroxime axetil: comparison of standard and abbreviated methods.
Lang CC; Moreland TA; Davey PG
J Antimicrob Chemother; 1990 Apr; 25(4):645-50. PubMed ID: 2351625
[TBL] [Abstract][Full Text] [Related]
20. Design of Fexofenadine Prodrugs Based on Tissue-Specific Esterase Activity and Their Dissimilar Recognition by P-Glycoprotein.
Ohura K; Nakada Y; Kotani S; Imai T
J Pharm Sci; 2015 Sep; 104(9):3076-83. PubMed ID: 25953731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]